Related Experiment Video

Updated: Aug 11, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

[Markers of coronary damage. From diagnosis to prognosis]

Marco Valgimigli1, Paolo A M Squasi, Stavroula Gaitani

  • 1Cattedra di Cardiologia, Università, Ferrara. vlgmrc@unife.it

Recenti Progressi in Medicina
|February 28, 2006
PubMed

Insights

New cardiac biomarkers, including inflammatory cytokines, show promise for diagnosing cardiac damage and predicting outcomes in cardiovascular disease patients. Further research is needed to define their role alongside troponin testing.

Area of Science:

  • Biochemistry
  • Cardiology
  • Clinical Diagnostics

Context:

  • Cardiovascular disease presents a significant public health challenge.
  • Accurate and rapid diagnosis of acute coronary syndrome (ACS) is crucial for effective treatment and improved patient outcomes.
  • Troponin levels are standard for detecting cardiac damage but do not differentiate causes of myocardial injury.

Purpose:

  • To review evidence on novel biological markers for cardiac damage, focusing on inflammatory cytokines in cardiovascular disease.
  • To explore the diagnostic and prognostic value of these new markers in patients with ACS and heart failure.

Summary:

  • Troponin measurements are established for risk stratification in chest pain patients.
  • Combining troponin with other biomarkers, such as inflammatory cytokines, may provide complementary information on pathophysiology, prognosis, and timing of myocardial injury.
  • While the role of inflammatory biomarkers is still under investigation, they show potential for understanding cardiovascular disease mechanisms and outcomes.

Impact:

  • Enhancing diagnostic accuracy for acute coronary syndrome.
  • Improving risk stratification and prognostic assessment in cardiovascular disease.
  • Providing insights into the pathophysiological mechanisms of myocardial injury.
Abstract

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...